LINKING METABOLIC DISORDERS AND IMMUNE SYSTEM PHENOMENA IN SCHIZOPHRENIA: THE ROLE OF ADIPOSE TISSUE AND INFLAMMATION

Descargar Publicación
Dietary supplement considerations during glucagon-like Peptide-1 receptor agonist treatment: A narrative review El futuro terapéutico de la obesidad: de los incretínicos a los súper poliagonistas